摘要 |
The present invention relates to tricyclic quinoline and quinoxaline derivatives, to a pharmaceutical composition containing such compounds, to their use as modulators, especially agonists or partial agonists, of the 5-HT2C receptor, their use for preparing a medicament for the prevention or treatment of conditions and disorders which respond to the modulation of 5-HT2C receptor, and to a method for preventing or treating conditions and disorders which respond to the modulation of 5-HT2C receptor. |
申请人 |
AbbVie Deutschland GmbH & Co. KG |
发明人 |
KOOLMAN, Hannes;BRAJE, Wilfried;MACK, Helmut;HAUPT, Andreas;RELO, Ana Lucia;DRESCHER, Karla;BAKKER, Margaretha Henrica Maria;LAKICS, Viktor;HOFT, Carolin;XU, Ruxu;ZHAO, Xiaona |